Thoracic and cardiovascular surgery in Japan during 2013
Thoracic and cardiovascular surgery in Japan during 2013
复制标题
DOI：
10.1007/s11748-015-0590-3
复制
发表时间：
2015-12-01
影响因子：
1.2
通讯作者：
Yokomise, Hiroyasu
中科院分区：
文献类型：
--
作者：
Masuda, Munetaka;Kuwano, Hiroyuki;Yokomise, Hiroyasu
自1987年以来，日本胸外科协会每年在日本各地进行胸外科调查，以确定根据手术类别进行的手术数量统计数据。在这里，我们总结了2012年胸外科手术的年度调查结果。调查中增加了医院死亡率，以确定全国范围内的状况，这有助于日本外科医生了解日本胸外科的现状，并通过与其他人的工作进行比较，在改善手术结果方面取得进展。该协会能够更好地了解目前的问题以及未来的前景，这反映在其活动中，包括对其成员的教育。30天死亡率（所谓的“手术死亡率”）定义为手术后30天内的死亡，无论患者的地理位置如何，即使患者已经出院。医院死亡率定义为手术后任何时间间隔内的死亡，如果患者没有出院。医院到医院的转移不被视为出院：转移到疗养院或康复单位被视为出院，除非患者随后死于手术并发症。胸外科医师协会人工心脏瓣膜病定义标准化特设联络委员会的定义，
The Japanese Association for Thoracic Surgery has conducted annual surveys of thoracic surgery throughout Japan since 1987 to determine the statistics regarding the number of procedures according to operative category. Here, we have summarized the results from our annual survey of thoracic surgery performed during 2012. The incidence of hospital mortality was added to the survey to determine the nationwide status, which has contributed to the Japanese surgeons to understand the present status of thoracic surgery in Japan and to make progress to improve operative results by comparing their work with those of others. The Association was able to gain a better understanding of the present problems as well as future prospects, which has been reflected to its activity including education of its members. Thirty-day mortality (so-called ‘‘operative mortality) is defined as death within 30 days of operation regardless of the patient’s geographic location and even though the patient had been discharged from the hospital.Hospital mortality is defined as death within any time interval after an operation if the patient had not been discharged from the hospital. Hospital-to-hospital transfer is not considered discharge: transfer to a nursing home or a rehabilitation unit is considered hospital discharge unless the patient subsequently dies of complications of the operation. The definitions of the Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of the Society of Thoracic Surgeons and